Transfected Stable Cell Lines
Reliable | High-Performance | Wide Rage
Precision reporter, kinase, immune receptor, biosimilar, Cas9, and knockout stable cell lines for diverse applications.
Cat. No. : CSC-RO1059
Host Cell : Jurkat Size : >1x106 frozen cells/vial
| Cat. No. | CSC-RO1059 |
| Description | Jurkat-TNFRSF1B cell line is engineered to stably overexpress human TNFRSF1B. |
| Target Gene | TNFRSF1B |
| Gene Species | Homo sapiens (Human) |
| Host Cell | Jurkat |
| Host Cell Species | Homo sapiens (Human) |
| Applications |
1. Studying the interactions between immune cells and cancer cells 2. Studying the mechanisms of resistance to immune checkpoint blockade 3. High-throughput screening 4. Drug target validation |
| Size | >1x106 frozen cells/vial |
| Stability | Validated for at least 10 passages |
| Quality Control | Negative for bacteria, yeast, fungi and mycoplasma. |
| Storage | Liquid nitrogen |
| Shipping | Dry ice |
| Revival | Rapidly thaw cells in a 37°C water bath. Transfer contents into a tube containing pre-warmed media. Centrifuge cells and seed into a 25 cm2 flask containing pre-warmed media. |
| Mycoplasma | Negative |
| Format | One frozen vial containing millions of cells |
| Storage | Liquid nitrogen |
| Safety Considerations |
The following safety precautions should be observed. 1. Use pipette aids to prevent ingestion and keep aerosols down to a minimum. 2. No eating, drinking or smoking while handling the stable line. 3. Wash hands after handling the stable line and before leaving the lab. 4. Decontaminate work surface with disinfectant or 70% ethanol before and after working with stable cells. 5. All waste should be considered hazardous. 6. Dispose of all liquid waste after each experiment and treat with bleach. |
| Ship | Dry ice |
| Gene Name | TNFRSF1B tumor necrosis factor receptor superfamily, member 1B [ Homo sapiens ] |
| Gene Symbol | TNFRSF1B |
| Synonyms | p75; TBPII; TNFBR; TNFR2; CD120b; TNFR1B; TNFR80; TNF-R75; p75TNFR; TNF-R-II |
| Gene Description | tumor necrosis factor receptor superfamily, member 1B |
| GeneID | 7133 |
| Uni ProtID | P20333 |
| mRNA Refseq | NM_001066.2 |
| Protein Refseq | NP_001057.1 |
| Chromosome Location | 1p36.22 |
| Function | protein binding; tumor necrosis factor-activated receptor activity; ubiquitin protein ligase binding; |
| Pathway | Adipocytokine signaling pathway, organism-specific biosystem; Adipocytokine signaling pathway, conserved biosystem; Amyotrophic lateral sclerosis (ALS), organism-specific biosystem; Amyotrophic lateral sclerosis (ALS), conserved biosystem; Apoptosis, organism-specific biosystem; Apoptosis Modulation and Signaling, organism-specific biosystem; Cytokine-cytokine receptor interaction, organism-specific biosystem; |
| MIM | 191191 |
A: The Human TNFRSF1B Stable Cell Line-Jurkat originated from the Jurkat cell line, which is a well-established human T lymphocyte cell line. The stable cell line was developed by introducing and maintaining a stable expression of the TNFRSF1B gene in Jurkat cells through genetic modification techniques. This modification allows the cells to express the TNFRSF1B receptor on their surface consistently.
A: The Human TNFRSF1B Stable Cell Line-Jurkat is primarily used in research related to the tumor necrosis factor receptor superfamily member 1B (TNFRSF1B) and its signaling pathways. Common applications include studying apoptosis, immune responses, and inflammation regulation. Additionally, it can be utilized in drug screening and development studies targeting TNFRSF1B.
A: To maintain the stability of the Human TNFRSF1B Stable Cell Line-Jurkat, researchers should culture the cells under appropriate conditions. This includes maintaining the expression of TNFRSF1B by supplementing the culture medium with selection markers like antibiotics or other selection agents. Regular monitoring of the cell line's phenotype and gene expression is crucial to ensure stability over time.
A: Researchers commonly investigate the signaling pathways associated with TNFRSF1B, such as the NF-κB pathway, MAPK pathway, and JAK-STAT pathway, using the Human TNFRSF1B Stable Cell Line-Jurkat. Downstream effects of TNFRSF1B activation, including cytokine production, cell proliferation, and apoptosis, are also studied to understand the receptor's role in immune and inflammatory responses.
A: Yes, when working with the Human TNFRSF1B Stable Cell Line-Jurkat, researchers need to consider the potential effects of TNFRSF1B overexpression on cell behavior and signaling. It's essential to carefully design experiments and controls to account for these changes. Additionally, maintaining stable expression of TNFRSF1B may require ongoing selection pressure to prevent loss of expression.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
Write a review of your use of Biogene products and services in your research. Your review can help your fellow researchers make informed purchasing decisions.